Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 473

1.

Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S.

Ann Fam Med. 2007 Mar-Apr;5(2):146-50.

2.

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D; Buprenorphine/Naloxone Collaborative Study Group..

N Engl J Med. 2003 Sep 4;349(10):949-58.

3.

A trial of integrated buprenorphine/naloxone and HIV clinical care.

Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S184-90.

PMID:
17109305
4.

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS.

N Engl J Med. 2006 Jul 27;355(4):365-74.

5.

Using buprenorphine for outpatient opioid detoxification.

Manlandro JJ Jr.

J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES11-6. Review.

PMID:
17908825
6.
7.

Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.

Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P.

Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000.

PMID:
20450243
8.

Opioid Addiction Treatment Using Buprenorphine-Naloxone In A Community-Based Internal Medicine Practice.

Van Doren BA, Foulks-Rodriguez KA, Yarborough W.

J Okla State Med Assoc. 2015 Jul;108(7):303-9.

PMID:
26390769
9.
10.

Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.

Montesano F, Zaccone D, Battaglia E, Genco F, Mellace V.

Clin Drug Investig. 2010;30 Suppl 1:13-9. doi: 10.2165/11536040-000000000-00000.

PMID:
20450241
11.

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

Resnick RB.

Ann Intern Med. 2003 Feb 18;138(4):360. No abstract available.

PMID:
12585846
12.

Initial strategies for integrating buprenorphine into HIV care settings in the United States.

Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. Review.

PMID:
17109306
13.

Buprenorphine for office-based treatment of patients with opioid addiction.

Manlandro JJ Jr.

J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13. Review.

PMID:
16118361
14.

Counseling buprenorphine patients: information and treatment approaches for counselors.

McCann MJ.

J Psychoactive Drugs. 2004 May;Suppl 2:139-46.

PMID:
15279126
15.

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS.

Am J Med. 1998 Aug;105(2):100-5.

PMID:
9727815
16.

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA.

Drug Alcohol Depend. 2005 Jul;79(1):113-6.

PMID:
15943950
17.

Buprenorphine and naloxone for heroin dependence.

Johnson RE, McCagh JC.

Curr Psychiatry Rep. 2000 Dec;2(6):519-26. Review.

PMID:
11123005
18.

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.

Strain EC, Stoller K, Walsh SL, Bigelow GE.

Psychopharmacology (Berl). 2000 Mar;148(4):374-83.

PMID:
10928310
19.

Helping 'them': our role in recovery from opioid dependence.

Loxterkamp D.

Ann Fam Med. 2006 Mar-Apr;4(2):168-71.

20.

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.

Mammen K, Bell J.

Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405. Review.

PMID:
19708849

Supplemental Content

Support Center